ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 239,99
0,17%
Dow Jones
39 908,00
0,88%
DAX
18 869,36
0,78%
Brent Oil
82,71
0,19%
Bitcoin
66 047,44
7,31%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Tandem Diabetes Care Inc (TNDM)

  7. Tandem Diabetes Care Inc (TNDM) Actualités

TNDM

Tandem Diabetes Care (TNDM)

Tandem Diabetes Care Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:TNDM
DateHeureSourceTitreSymboleSociété
02/05/202422h05Business WireTandem Diabetes Care Announces First Quarter 2024 Financial Results and Updates Full Year 2024 Financial GuidanceNASDAQ:TNDMTandem Diabetes Care Inc
29/04/202422h05Business WireTandem Diabetes Care Announces Upcoming Conference PresentationsNASDAQ:TNDMTandem Diabetes Care Inc
09/04/202422h05Business WireTandem Diabetes Care to Announce First Quarter 2024 Financial Results on May 2, 2024NASDAQ:TNDMTandem Diabetes Care Inc
18/03/202414h05GlobeNewswire Inc.Parexel Announces CEO Succession PlanNASDAQ:TNDMTandem Diabetes Care Inc
06/03/202406h46Business WireTandem Diabetes Care Prices Upsized Private Placement of $275.0 Million of Convertible Senior Notes Due 2029NASDAQ:TNDMTandem Diabetes Care Inc
04/03/202422h05Business WireTandem Diabetes Care Announces Proposed Private Placement of Convertible NotesNASDAQ:TNDMTandem Diabetes Care Inc
29/02/202423h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
21/02/202422h33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TNDMTandem Diabetes Care Inc
21/02/202422h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNDMTandem Diabetes Care Inc
21/02/202422h05Business WireTandem Diabetes Care Announces Fourth Quarter and Full Year 2023 Financial Results and 2024 Financial GuidanceNASDAQ:TNDMTandem Diabetes Care Inc
13/02/202414h30Business WireTandem Diabetes Care Launches Tandem Mobi, the World’s Smallest, Durable Automated Insulin Delivery SystemNASDAQ:TNDMTandem Diabetes Care Inc
22/01/202422h05Business WireTandem Diabetes Care to Announce Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024NASDAQ:TNDMTandem Diabetes Care Inc
08/01/202414h00Business WireTandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus SensorNASDAQ:TNDMTandem Diabetes Care Inc
12/12/202322h15Business WireTandem Diabetes Care Announces Full U.S. Launch of Tandem Source, a New Diabetes Management Platform for Customers and Healthcare ProvidersNASDAQ:TNDMTandem Diabetes Care Inc
06/12/202314h30Business WireTandem Diabetes Care Launches t:slim X2 Insulin Pump Software with Dexcom G7 CGM Integration in U.S.NASDAQ:TNDMTandem Diabetes Care Inc
17/11/202322h14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TNDMTandem Diabetes Care Inc
01/11/202321h08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TNDMTandem Diabetes Care Inc
01/11/202321h06Business WireTandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial OfficerNASDAQ:TNDMTandem Diabetes Care Inc
01/11/202321h02Business WireTandem Diabetes Care Announces Third Quarter 2023 Financial ResultsNASDAQ:TNDMTandem Diabetes Care Inc
31/10/202310h45PR Newswire (US)SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of November 7, 2023 - (NASDAQ: TNDM)NASDAQ:TNDMTandem Diabetes Care Inc
10/10/202322h05Business WireTandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023NASDAQ:TNDMTandem Diabetes Care Inc
03/08/202322h21Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TNDMTandem Diabetes Care Inc
03/08/202322h06Business WireTandem Diabetes Care Announces Technology Access Program to Provide Customers with Purchase Pathway to the Tandem Mobi SystemNASDAQ:TNDMTandem Diabetes Care Inc
03/08/202322h02Business WireTandem Diabetes Care Announces Second Quarter 2023 Financial Results and Updated Full Year 2023 Financial GuidanceNASDAQ:TNDMTandem Diabetes Care Inc
01/08/202322h05Business WireTandem Diabetes Care to Present at the UBS MedTech, Tools and Genomics Summit 2023NASDAQ:TNDMTandem Diabetes Care Inc
26/07/202311h45PR Newswire (US)INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Tandem Diabetes Care, Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: TNDM)NASDAQ:TNDMTandem Diabetes Care Inc
21/07/202311h45PR Newswire (US)TNDM FRAUD ALERT: Jakubowitz Law is Investigating Tandem Diabetes Care, Inc. in Connection with Potential Violations of Federal Securities LawsNASDAQ:TNDMTandem Diabetes Care Inc
11/07/202317h01Dow Jones NewsTandem Diabetes Care Shares Gain 9.7% on FDA OKNASDAQ:TNDMTandem Diabetes Care Inc
11/07/202315h49Dow Jones NewsTandem Diabetes Care Gets FDA OK for Smallest Durable Insulin Delivery SystemNASDAQ:TNDMTandem Diabetes Care Inc
11/07/202315h00Business WireTandem Mobi, World’s Smallest Durable Insulin Delivery System, Receives FDA ClearanceNASDAQ:TNDMTandem Diabetes Care Inc
 Showing the most relevant articles for your search:NASDAQ:TNDM

Dernières Valeurs Consultées

NASDAQ
FANH
Fanhua
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés